JP2024538694A5 - - Google Patents

Info

Publication number
JP2024538694A5
JP2024538694A5 JP2024520826A JP2024520826A JP2024538694A5 JP 2024538694 A5 JP2024538694 A5 JP 2024538694A5 JP 2024520826 A JP2024520826 A JP 2024520826A JP 2024520826 A JP2024520826 A JP 2024520826A JP 2024538694 A5 JP2024538694 A5 JP 2024538694A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
haloalkyl
pharmaceutically acceptable
heteroatoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024520826A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538694A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/077501 external-priority patent/WO2023060057A1/en
Publication of JP2024538694A publication Critical patent/JP2024538694A/ja
Publication of JP2024538694A5 publication Critical patent/JP2024538694A5/ja
Pending legal-status Critical Current

Links

JP2024520826A 2021-10-05 2022-10-04 シクロペンチルピラゾールcdk2阻害剤 Pending JP2024538694A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163252394P 2021-10-05 2021-10-05
US63/252,394 2021-10-05
PCT/US2022/077501 WO2023060057A1 (en) 2021-10-05 2022-10-04 Cyclopentylpyrazole cdk2 inhibitors

Publications (2)

Publication Number Publication Date
JP2024538694A JP2024538694A (ja) 2024-10-23
JP2024538694A5 true JP2024538694A5 (https=) 2025-10-10

Family

ID=84245758

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024520826A Pending JP2024538694A (ja) 2021-10-05 2022-10-04 シクロペンチルピラゾールcdk2阻害剤

Country Status (10)

Country Link
US (1) US20240425478A1 (https=)
EP (1) EP4412995A1 (https=)
JP (1) JP2024538694A (https=)
KR (1) KR20240077491A (https=)
CN (1) CN118019734A (https=)
AR (1) AR127247A1 (https=)
AU (1) AU2022360968A1 (https=)
CA (1) CA3229067A1 (https=)
TW (1) TW202330501A (https=)
WO (1) WO2023060057A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240020735A (ko) 2021-05-07 2024-02-15 카이메라 쎄라퓨틱스 인코포레이티드 Cdk2 분해제 및 그 용도
CN119072471A (zh) * 2022-04-28 2024-12-03 正大天晴药业集团股份有限公司 一种吡唑取代环戊酯衍生物及其用途
CN120239698A (zh) * 2022-11-17 2025-07-01 山东绿叶制药有限公司 Cdk2抑制剂及其制备方法和应用
WO2025136671A1 (en) * 2023-12-20 2025-06-26 Ensem Therapeutics, Inc. Anilino-pyrazole derivatives, compositions and methods thereof
WO2026024674A1 (en) 2024-07-22 2026-01-29 Genesis Therapeutics, Inc. Methods of treating skp2-associated cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL284589B2 (en) * 2019-01-31 2025-10-01 Pfizer 3–Carbonylamino–5–cyclopentyl–h1–pyrazole compounds with cdk2 inhibitory activity
CN113766125B (zh) 2019-09-29 2022-10-25 Oppo广东移动通信有限公司 对焦方法和装置、电子设备、计算机可读存储介质
WO2022174031A1 (en) * 2021-02-12 2022-08-18 Relay Therapeutics, Inc. Cdk inhibitors and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2024538694A5 (https=)
JP2024543975A5 (https=)
JP2024543976A5 (https=)
JP2023052094A5 (https=)
JP2022544714A5 (https=)
RU2353616C2 (ru) Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
JP2021523099A5 (https=)
JP2021522281A5 (https=)
JP2023515618A5 (https=)
RU2016150486A (ru) Ингибиторы бета-лактамазы
JP2019509276A5 (https=)
JP2023504542A5 (https=)
JP2006515858A5 (https=)
JP2007508305A5 (https=)
KR920702349A (ko) N-치환 복소환식 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물
JP2017504595A5 (https=)
RU2010116253A (ru) Производные n-гидроксилсульфонамида как новые физиологически применимые доноры нитроксила
JP2020527175A5 (https=)
RU2009102270A (ru) Производные тиазолилмочевины в качестве ингибиторов фосфатидилинозитол-3-киназы
JP2022533939A5 (https=)
JP2018510202A5 (https=)
JP2022501334A5 (https=)
JP2021535213A5 (https=)
JP2020511547A5 (https=)
JP2023553428A5 (https=)